TY - JOUR
T1 - A perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessment
AU - Kullo, Iftikhar J.
N1 - Funding Information:
Grant Support: Dr Kullo is supported by grants HG006379 from the National Human Genome Research Institute and HL112677 from the National Heart, Lung, and Blood Institute .
Publisher Copyright:
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - The recently published American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cardiovascular risk assessment provide equations to estimate the 10-year and lifetime atherosclerotic cardiovascular disease (ASCVD) risk in African Americans and non-Hispanic whites, include stroke as an adverse cardiovascular outcome, and emphasize shared decision making. The guidelines provide a valuable framework that can be adapted on the basis of clinical judgment and individual/institutional expertise. In this review, we provide a perspective on the new guidelines, highlighting what is new, what is controversial, and potential adaptations. We recommend obtaining family history of ASCVD at the time of estimating ASCVD risk and consideration of imaging to assess subclinical disease burden in patients at intermediate risk. In addition to the adjuncts for ASCVD risk estimation recommended in the guidelines, measures that may be useful in refining risk estimates include carotid ultrasonography, aortic pulse wave velocity, and serum lipoprotein(a) levels. Finally, we stress the need for research efforts to improve assessment of ASCVD risk given the suboptimal performance of available risk algorithms and suggest potential future directions in this regard.
AB - The recently published American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cardiovascular risk assessment provide equations to estimate the 10-year and lifetime atherosclerotic cardiovascular disease (ASCVD) risk in African Americans and non-Hispanic whites, include stroke as an adverse cardiovascular outcome, and emphasize shared decision making. The guidelines provide a valuable framework that can be adapted on the basis of clinical judgment and individual/institutional expertise. In this review, we provide a perspective on the new guidelines, highlighting what is new, what is controversial, and potential adaptations. We recommend obtaining family history of ASCVD at the time of estimating ASCVD risk and consideration of imaging to assess subclinical disease burden in patients at intermediate risk. In addition to the adjuncts for ASCVD risk estimation recommended in the guidelines, measures that may be useful in refining risk estimates include carotid ultrasonography, aortic pulse wave velocity, and serum lipoprotein(a) levels. Finally, we stress the need for research efforts to improve assessment of ASCVD risk given the suboptimal performance of available risk algorithms and suggest potential future directions in this regard.
UR - http://www.scopus.com/inward/record.url?scp=85027947894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027947894&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2014.06.018
DO - 10.1016/j.mayocp.2014.06.018
M3 - Review article
C2 - 25131696
AN - SCOPUS:85027947894
SN - 0025-6196
VL - 89
SP - 1244
EP - 1256
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 9
ER -